Le Lézard
Classified in: Health
Subjects: NPT, CHI, TRI

Announcing 2023 Infrastructure Grants to Support Clinical Trials


LOS ANGELES, Nov. 21, 2023 /PRNewswire/ -- The St. Baldrick's Foundation, the largest charity funder of childhood cancer research grants, is thrilled to announce $1.1 million in new grants to bolster pediatric cancer clinical trial enrollment. Clinical trials play a crucial role in the fight against childhood cancer. The unsung heroes who help make clinical trials happen for kids are the dedicated clinical research associates, nurses, and support staff.   

This $1.1 million supports these necessary roles to ensure more kids get treated on a clinical trial, often their best hope for a cure.  

These grants would not be possible without the support of St. Baldrick's volunteers, supporters and donors.

The following institutions were awarded a St. Baldrick's Foundation Infrastructure award: 

CALIFORNIA 

FLORIDA 

ILLINOIS 

IOWA 

LOUISIANA 

MICHIGAN 

MISSOURI 

NORTH CAROLINA 

NEW JERSEY 

NEW MEXICO 

NEVADA 

NEW YORK 

TEXAS 

VIRGINIA 

WISCONSIN  

The next set of grants will be announced in March, supported by donations made now. Visit the?St. Baldrick's Foundation grants page?to learn more about all the research these grants are supporting. 

About St. Baldrick's Foundation??
Every 2 minutes, a child somewhere is diagnosed with cancer. In the U.S., 1 in 5 will not survive. The St. Baldrick's Foundation, the largest charity funder of childhood cancer research grants, is on a mission to Conquer Kids' Cancer by supporting the most promising research to find cures and better treatments for all childhood cancers. When you give to St. Baldrick's, you don't just give to one hospital ? you support virtually every institution with the expertise to treat kids with cancer across the U.S. St. Baldrick's ensures that children fighting cancer now ? and those diagnosed in the future ? will have access to the most cutting-edge treatment, by supporting every stage of research, from new ideas in the lab to the training of the next generation of researchers, to life-saving clinical trials. Visit StBaldricks.org and help #ConquerKidsCancer.?

SOURCE St. Baldrick's Foundation


These press releases may also interest you

at 21:30
The "Hydroxypropyl Methylcellulose Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to  ResearchAndMarkets.com's offering. The latest industry analysis on the Hydroxypropyl Methylcellulose...

at 21:00
The "Asia-Pacific Contrast Media Agent and Injector System Market - Analysis and Forecast, 2022-2026" report has been added to  ResearchAndMarkets.com's offering. The Asia-Pacific contrast media agent and injector system market was valued at $1.98...

at 20:50
Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the pricing of its  underwritten public offering of 6,471,000...

at 20:34
The Honourable Mark Holland, Minister of Health, will make an announcement related to An Act Respecting Pharmacare. There will be a virtual media technical briefing with Government of Canada officials prior to the press conference. DateFebruary 29,...

at 19:30
The "Protein Expression Market - A Global and Regional Analysis: Focus on Application, End User, Product, Expression System, and Region - Analysis and Forecast, 2023-2033" report has been added to  ResearchAndMarkets.com's offering. The global...

at 19:20
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, today announced that MSCI, one of the...



News published on and distributed by: